Association of GST polymorphism with adverse drug reactions: an analysis across multiple drug categories

Soukaina Ettoury,Sara Louati,Ibtissam Saad,Kaoutar Bentayebi,Omaima Zarrik,Jamal Eddine Bourkadi,Youssef Daali,Lahcen Belyamani,Rachid Eljaoudi

DOI: https://doi.org/10.1080/17425255.2024.2426616

2024-11-08

Expert Opinion on Drug Metabolism & Toxicology

Abstract:Introduction Adverse drug reactions (ADRs) pose a significant challenge in clinical practice, impacting patient safety and treatment outcomes. Genetic variations in drug-metabolizing enzymes, particularly glutathione S-transferases (GSTs), have been implicated in modulating individual susceptibility to ADRs.

pharmacology & pharmacy,biochemistry & molecular biology,toxicology